foxo4-dri human study senolytic peptide trial Computational design of targeting FOXO4. a, Domains of FOXO4 foxo4 dri senolytic 2024 – FOXO4-DRI — ≥99% Purity, COA
Pay in 4 interest-free payments of $7.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
FOXO4 DRI 99% Purity, COA Included Glow Peptides FOXO4 DRI (Proxofim) (10mg) Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology
Store: larengifo.com · Domain: larengifo.com






















